Pharmaceutical company “Darnytsia” together with the Ukrainian Pharmaceutical Students’ Association (UPSA) are preparing a series of podcasts about pharmaceutics. Company experts will tell students about clinical trials, registration, production, logistics,…
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…